6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow Acne Inversa: new trials by email Literature Review of Acne Inversa trials Research Report on Acne Inversa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anifrolumab for Hidradenitis Suppurativa Anifrolumab - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | University of North Carolina, Chapel Hill | 15 | 2024-06-21 | 2026-08-03 |
| To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa INCB054707, Placebo - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | Incyte Corporation | 209 | 2020-08-25 | 2025-08-12 |
| A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa PF-06650833, PF-06700841, PF-06826647 - Acne Inversa | Phase 2 | Completed | Pfizer | 194 | 2019-12-02 | 2023-06-15 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa bermekimab, placebo - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | Janssen Research & Development, LLC | 153 | 2019-09-16 | 2023-07-27 |
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Avacopan, Placebo - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | Amgen | 435 | 2018-12-21 | 2025-03-17 |
| Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Hydroxychloroquine - Hidradenitis Suppurativa, Hidradenitis | Phase 1 / Phase 2 | Completed | Elena Gonzalez Brant, MD | 17 | 2017-09-28 | 2020-04-02 |
Hidradenitis Suppurativa (6) · Hidradenitis (2) · Abscess (1) · Furunculosis (1) · Skin Diseases (1)
Bacterial Infections (6) · Bacterial Infections and Mycoses (6) · Infections (6) · Skin Diseases, Bacterial (6) · Skin Diseases, Infectious (6) · Skin and Connective Tissue Diseases (6) · Suppuration (6) · Sweat Gland Diseases (6) · Skin Diseases (5) · Hidradenitis (4) · Animal Diseases (1) · Fish Diseases (1) · Gram-Positive Bacterial Infections (1) · Inflammation (1) · Pathologic Processes (1)
1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide (1) · Hydroxychloroquine (1) · PF-06700841 (1) · anifrolumab (1) · avacopan (1) · bermekimab (1) · ropsacitinib (1)
Amgen (1) · Elena Gonzalez Brant, MD (1) · Incyte Corporation (1) · Janssen Research & Development, LLC (1) · Pfizer (1) · University of North Carolina, Chapel Hill (1)
United States (6) · Canada (2) · Australia (1) · France (1) · Germany (1) · Poland (1) · Spain (1)
Christopher Sayed, MD (1) · Elena M Gonzalez Brant, MD (1)